The Cannabis plant produces more than 400 bioactive molecules. The challenge is to make purposeful efficient drugs in a reasonable and cost-efficient time frame from such a resource.
Chain Pharmaceuticals is researching developing Phytocannabinoid Medicines that enable healthcare professionals to optimize patient treatments.
![](https://chainpharmaceuticals.com/wp-content/uploads/2022/03/CHAIN-AI-scaled-e1647034054251.jpg)
HealCHAIN
The HealChain app empowers its users to take control of their health and their data. By allowing cannabis patients to share their own real-world data in exchange for accurate, timely resources related to their conditions, HealChain unlocks the value of personal health information.
![](https://chainpharmaceuticals.com/wp-content/uploads/2022/03/healCHAIN-scaled-e1647033571566-1024x621.jpg)
![](https://chainpharmaceuticals.com/wp-content/uploads/2022/03/About-CHAIN.jpg)
Chain Pharmaceuticals
Our Vision is to be a leader in decentralised and personalised phytochemical based healthcare solutions through an innovative portfolio of AI refined pharmaceutical products.
Our Partners
Recent News
Chain Pharmaceuticals GmbH kündigt Arzneimittelforschungs-Plattform für Phytocannabinoide an
Das Unternehmen wird die Entdeckung von marktzulässigen, fertigen Arzneimitteln vorantreiben, die die Nachfrage nach personalisierten Therapien decken. Frankfurt am Main, Deutschland,15. November 2022: Dr. Pierre Debs, Ph.D., gab heute die…